# CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy

Article · Amira A. Barkal, Rachel E. Brewer, Maxim Markovic, Mark Kowarsky, Sammy A. Barkal, Balyn W. Zaro, Venkatesh Krishnan, Jason Hatakeyama, Oliver Dorigo, Layla J. Barkal, Irving L. Weissman

- Archive id: doi:10.1038/s41586-019-1456-0
- Published: 2019-07-31
- Venue: Nature
- DOI: https://doi.org/10.1038/s41586-019-1456-0
- PMID: 31367043
- Citations: 1,394
- Source URL: https://doi.org/10.1038/s41586-019-1456-0
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Cancer Immunotherapy](https://space-kitty.com/topics/cancer-immunotherapy)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.